| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0005 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0008 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.098 | 0.001 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |